Carl Zeiss Meditec AG (AFX)

Industry Medical Instruments & Supplies
This stock can be held in an Investment ISA and an Investment Account
Sell

€24.64

Buy

€25.14

arrow-up€0.30 (+1.21%)

Prices updated at 02 Apr 2026, 20:05 CEST
| Prices minimum 15 mins delay
|
Prices in EUR
Carl Zeiss Meditec AG offers end-to-end solutions for the diagnosis and treatment of ophthalmic diseases, including implants and consumables. It provides visualization solutions in microsurgery. It offers its solutions to physicians and hospitals.
FTSE EuroFirst 300
arrow-down-0.19%
Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and
Our Investment Fees and Charges.

Most recent dividend payment

0.550
Cash Dividend
27 Mar 2026
05 Feb 2026
30 Mar 2026
31 Mar 2026

Total dividend yield

Dividend history and forecast data table

YearDividend per shareDividend growth (%)
20260.5500-
20250.6000-0.45
20241.1000-
20231.10000.22
20220.90000.80
20210.5000-0.23
20200.65000.18
20190.5500-
20180.55000.31
20170.42000.11

Total dividend yield data table

Year
chevron-l-regular
chevron-r-regular
Dividend yield (%)Buyback yield (%)
20262.27-
20251.50-
20242.423.77
20231.11-
20220.76-
20210.27-
20200.60-
20190.48-
20180.81-
20170.81-

Dividend per share

% of earnings paid to shareholders

Dividend per share data table

YearDividend per share
20260.5500
20250.6000
20241.1000
20231.1000
20220.9000
20210.5000
20200.6500
20190.5500
20180.5500
20170.4200

% of earnings paid to shareholders data table

YearPayout ratio (%)
202637.27
202537.27
202454.73
202333.85
202227.36
202118.94
202047.45
201930.73
201839.01
201726.75
Latest Financial Report as of 02 Apr 2026
Dividend amount and dividend per share are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2026 Morningstar. All rights reserved.